PR NEWSWIRE

Previous Stories

P&G Australia “Leads with Love” in Largest-Ever Activation with Sydney WorldPride and Sydney Gay and Lesbian Mardi Gras

Feb 09 2023 - PR NewsWire

SYDNEY, Feb. 9, 2023 /PRNewswire/ – Procter & Gamble (P&G) Australia, the creators of Pantene, Oral-B, Gillette, Olay, Fairy and VÖOST,…


InStyle Australia announces the cover star of its February edition as Chilli Heeler, star of award-winning ABC KIDS animated series Bluey

Feb 09 2023 - PR NewsWire

SYDNEY, Feb. 9, 2023 /PRNewswire/ — An exclusive collaboration between InStyle Australia and Ludo Studio, this very special cover shows…


6clicks Adds GPT-3 to Accelerate Risk Management, Automate Compliance Mapping and Advance Accuracy

Feb 09 2023 - PR NewsWire

Complex Natural Language Comprehension from OpenAI Adds "Ask Hailey" Understanding of Language Nuances to Powerful 6clicks GRC AI Engine MELBOURNE,…


Kohle Capital Markets (KCM) Marked another Milestone with the sponsorship of ACJC in February 2023 in Melbourne

Feb 08 2023 - PR NewsWire

MELBOURNE, Australia, Feb. 8, 2023 /PRNewswire/ — An auspicious start to the year 2023, Kohle Capital Markets’ (KCM) first sponsored event…


AI job interview tool releases new feature enabling companies to gauge candidate communication skills without resumes

Feb 08 2023 - PR NewsWire

MELBOURNE, Australia, Feb. 8, 2023 /PRNewswire/ – Sapia.ai, creator of the world’s first AI Smart Interviewer, has released a communication score…


Everyday Market from Woolworths Expands Online Marketplace with CommerceHub

Feb 08 2023 - PR NewsWire

The partnership gives more brands access to Australia’s largest retailer MELBOURNE, Australia, Feb. 8, 2023 /PRNewswire/ – CommerceHub, one of the…


Quadcode Markets wraps up 2022 as Australia’s best for trading

Feb 07 2023 - PR NewsWire

Australian broker QCM bursts into 2023 with three prestigious international awards — just a year after its market debut. It…


Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate C

Feb 07 2023 - PR NewsWire

MELBOURNE, Australia, Feb. 7, 2023 /PRNewswire/ — Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focusing on developing novel therapeutics for…


Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis

Feb 07 2023 - PR NewsWire

First targeted therapy available for the treatment of two main types of ANCA-associated vasculitis (AAV), a rare and systemic disease…


Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients

Feb 06 2023 - PR NewsWire

Data from Certa Therapeutics’ Phase 2 clinical trial with development candidate FT011 demonstrates clinically meaningful improvements for more than 60…


Analyse The Market From A Different Angle